Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR EUR (GBP) | CE2DRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.2 | 17.2 | -3.6 | 13.2 | 7.1 | |
+/-Cat | -2.1 | 1.8 | 4.7 | 1.6 | 1.3 | |
+/-B’mrk | -0.4 | -0.5 | 1.0 | 0.0 | -0.3 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 30/10/2024 | GBX 5509.50 | |
Day Change | -0.69% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 417 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1737652310 | |
Fund Size (Mil) 30/10/2024 | EUR 4305.33 | |
Share Class Size (Mil) 30/10/2024 | EUR 315.02 | |
Ongoing Charge 18/06/2024 | 0.12% |
Investment Objective: Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR EUR (GBP) | CE2D |
To track the performance of MSCI Europe Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Isabelle Lafargue 07/09/2015 | ||
Inception Date 19/12/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR EUR (GBP) | CE2D | 28/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 3.24 |
ASML Holding NV | Technology | 2.55 |
Nestle SA | Consumer Defensive | 2.30 |
SAP SE | Technology | 2.26 |
AstraZeneca PLC | Healthcare | 2.10 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR EUR (GBP) | CE2D |